131 related articles for article (PubMed ID: 16935385)
1. Pravastatin reduces lung metastasis of rat hepatocellular carcinoma via a coordinated decrease of MMP expression and activity.
Taras D; Blanc JF; Rullier A; Dugot-Senant N; Laurendeau I; Vidaud M; Rosenbaum J
J Hepatol; 2007 Jan; 46(1):69-76. PubMed ID: 16935385
[TBL] [Abstract][Full Text] [Related]
2. Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition.
Taras D; Blanc JF; Rullier A; Dugot-Senant N; Laurendeau I; Bièche I; Pines M; Rosenbaum J
Neoplasia; 2006 Apr; 8(4):312-8. PubMed ID: 16756723
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of extracellular matrix in the liver induces high metastatic potential of hepatocellular carcinoma to the lung.
Sawada S; Murakami K; Murata J; Tsukada K; Saiki I
Int J Oncol; 2001 Jul; 19(1):65-70. PubMed ID: 11408924
[TBL] [Abstract][Full Text] [Related]
4. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure.
Ichihara S; Noda A; Nagata K; Obata K; Xu J; Ichihara G; Oikawa S; Kawanishi S; Yamada Y; Yokota M
Cardiovasc Res; 2006 Feb; 69(3):726-35. PubMed ID: 16165109
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma and cardiac matrix metalloproteinase activities in patients with coronary artery disease and treated with pravastatin.
Fujiwara T; Saito S; Osanai T; Kameda K; Abe N; Higuma T; Yokoyama J; Hanada H; Fukui K; Fukuda I; Okumura K
Eur J Pharmacol; 2008 Oct; 594(1-3):146-51. PubMed ID: 18703045
[TBL] [Abstract][Full Text] [Related]
7. Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction.
Nakaya R; Uzui H; Shimizu H; Nakano A; Mitsuke Y; Yamazaki T; Ueda T; Lee JD
Int J Cardiol; 2005 Oct; 105(1):67-73. PubMed ID: 16207547
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
Yasuda S; Miyazaki S; Kinoshita H; Nagaya N; Kanda M; Goto Y; Nonogi H
Clin Sci (Lond); 2007 Jan; 112(1):43-9. PubMed ID: 16939410
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A inhibits the expression of membrane type-I matrix metalloproteinase in gingiva.
Chiu HC; Lu YT; Chin YT; Tu HP; Chiang CY; Gau CH; Nieh S; Fu E
J Periodontal Res; 2009 Jun; 44(3):338-47. PubMed ID: 19210333
[TBL] [Abstract][Full Text] [Related]
11. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
Kilian M; Gregor JI; Heukamp I; Hanel M; Ahlgrimm M; Schimke I; Kristiansen G; Ommer A; Walz MK; Jacobi CA; Wenger FA
Prostaglandins Leukot Essent Fatty Acids; 2006 Dec; 75(6):429-34. PubMed ID: 17034997
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
[TBL] [Abstract][Full Text] [Related]
14. Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model.
Arlt M; Kopitz C; Pennington C; Watson KL; Krell HW; Bode W; Gansbacher B; Khokha R; Edwards DR; Krüger A
Cancer Res; 2002 Oct; 62(19):5543-50. PubMed ID: 12359766
[TBL] [Abstract][Full Text] [Related]
15. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
16. Black tea polyphenols target matrix metalloproteinases, RECK, proangiogenic molecules and histone deacetylase in a rat hepatocarcinogenesis model.
Murugan RS; Vinothini G; Hara Y; Nagini S
Anticancer Res; 2009 Jun; 29(6):2301-5. PubMed ID: 19528495
[TBL] [Abstract][Full Text] [Related]
17. Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.
Sivaramakrishnan V; Niranjali Devaraj S
Chem Biol Interact; 2009 Aug; 180(3):353-9. PubMed ID: 19539802
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinase-2 and -9 and of tissue inhibitor of matrix metalloproteinase-1 in liver regeneration from oval cells in rat.
Pham Van T; Couchie D; Martin-Garcia N; Laperche Y; Zafrani ES; Mavier P
Matrix Biol; 2008 Oct; 27(8):674-81. PubMed ID: 18678246
[TBL] [Abstract][Full Text] [Related]
19. Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms.
Mateos-Cáceres PJ; López-Farré AJ; Morata PC; Ramos-Mozo P; Macaya C; Serrano FJ; Moñux G
Can J Physiol Pharmacol; 2008 Jul; 86(7):431-7. PubMed ID: 18641692
[TBL] [Abstract][Full Text] [Related]
20. Bacoside A downregulates matrix metalloproteinases 2 and 9 in DEN-induced hepatocellular carcinoma.
Janani P; Sivakumari K; Geetha A; Yuvaraj S; Parthasarathy C
Cell Biochem Funct; 2010 Mar; 28(2):164-9. PubMed ID: 20084675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
